男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

視網(wǎng)膜劈裂蛋白(RS)多克隆抗體

Polyclonal Antibody to Retinoschisin (RS)

RS1; XLRS1; Retinoschisis X-Linked,Juvenile 1; X-linked juvenile retinoschisis protein

  • 視網(wǎng)膜劈裂蛋白(RS)多克隆抗體產(chǎn)品包裝(模擬)
  • 視網(wǎng)膜劈裂蛋白(RS)多克隆抗體產(chǎn)品包裝(模擬)
  • PAJ847Hu01.jpgFigure. Western Blot; Sample: Recombinant RS, Human.
  • 視網(wǎng)膜劈裂蛋白(RS)多克隆抗體Western Blot; Sample:Porcine Eye lysate; <br/>Primary Ab: 1μg/ml Rabbit Anti-Human RS Antibody<br/>Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對RS的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別RS。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPJ847Hu01視網(wǎng)膜劈裂蛋白(RS)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAJ847Hu01視網(wǎng)膜劈裂蛋白(RS)多克隆抗體WB
MAJ847Hu21視網(wǎng)膜劈裂蛋白(RS)單克隆抗體WB; IHC; ICC; IP.
SEJ847Hu視網(wǎng)膜劈裂蛋白(RS)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCJ847Hu視網(wǎng)膜劈裂蛋白(RS)檢測試劑盒(化學(xué)發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMJ847Hu視網(wǎng)膜劈裂蛋白(RS)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻

雜志參考文獻
Hum Gene TherDextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis.[PubMed: 22295905]
IEEE Transactions on MagneticsInfluence of Iron Oxide Nanoparticles on Innate and Genetically Modified Secretion Profiles of Mesenchymal Stem Cells[Scholarsportal: Source]
International Journal of PharmaceuticsA novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases[Pubmed:24576595]
22Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles[Pubmed:26986855]
UBC LibraryCell based therapeutics for retinal degenerations[cIRcle:1.0303136]
Molecular VisionAn ex vivo gene therapy approach in X-linked retinoschisis[pubmed:27390514]